Adenosine neuromodulation and traumatic brain injury

Current Neuropharmacology

Volumn 7, Issue 3, 2009, Pages 228-237

  Lusardi, T A ^a,b  

^a RS Dow Neurobiology Laboratories   (United States)

^b NONE   (United States)

Author keywords

Adenosine deaminase; Adenosine kinase; Caffeine; Comorbidity; Nucleoside transport; Nucleotidase

Indexed keywords

2 CHLOROADENOSINE; 5' NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; CAFFEINE; CYCLIC AMP;

ANAEROBIC METABOLISM; BRAIN BLOOD FLOW; BRAIN LEVEL; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; COMORBIDITY; DRUG MECHANISM; ENZYME ACTIVITY; EPILEPSY; HEMODYNAMICS; HUMAN; INFLAMMATION; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; NUCLEOSIDE TRANSPORT; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

EID: 70349690136     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015909789152137     Document Type: Review

References (150)

1. Abbott, C.A., Baker, E., Sutherland, G.R., McCaughan, G.W. (1994) Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics, 40, 331-338.
2. Abrams, T.W. (2009) Cyclic AMP (cAMP) Role in Learning and Memory. In: Squire, L.R. Ed, Encyclopedia of Neuroscience. Academic Press: Oxford, pp. 265-277.
3. Al Moutaery, K., Al Deeb, S., Ahmad Khan, H., Tariq, M. (2003) Caffeine impairs short-term neurological outcome after concussive head injury in rats. Neurosurgery, 53, 704-711; discussion 711-702.
4. Almeida, T., Rodrigues, R.J., de Mendonca, A., Ribeiro, J.A., Cunha, R.A. (2003) Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience, 122, 111-121.
5. Antoni, F.A. (2000) Molecular diversity of cyclic AMP signalling. Front. Neuroendocrinol., 21, 103-132.
6. Aoyama, N., Lee, S.M., Moro, N., Hovda, D.A., Sutton, R.L. (2008) Duration of ATP reduction affects extent of CA1 cell death in rat models of fluid percussion injury combined with secondary ischemia. Brain Res., 1230, 310-319.
7. Atkins, C.M., Oliva, A.A., Jr., Alonso, O.F., Pearse, D.D., Bramlett, H.M., Dietrich, W.D. (2007) Modulation of the cAMP signaling pathway after traumatic brain injury. Exp. Neurol., 208, 145-158.
8. Azdad, K., Gall, D., Woods, A.S., Ledent, C., Ferre, S., Schiffmann, S.N. (2009) Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization. Neuropsychopharmacology, 34, 972-986.
9. Ballarin, M., Fredholm, B.B., Ambrosio, S., Mahy, N. (1991) Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand., 142, 97-103.
10. Baraldi, P.G., Cacciari, B., Romagnoli, R., Merighi, S., Varani, K., Borea, P.A., Spalluto, G. (2000) A(3) adenosine receptor ligands: history and perspectives. Med. Res. Rev., 20, 103-128.
11. Baraldi, P.G., Tabrizi, M.A., Gessi, S., Borea, P.A. (2008) Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem. Rev., 108, 238-263.
12. Beldi, G., Enjyoji, K., Wu, Y., Miller, L., Banz, Y., Sun, X., Robson, S.C. (2008) The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Front. Biosci., 13, 2588-2603.
13. Bell, M.J., Kochanek, P.M., Carcillo, J.A., Mi, Z., Schiding, J.K., Wisniewski, S.R., Clark, R.S., Dixon, C.E., Marion, D.W., Jackson, E. (1998) Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma, 15, 163-170.
14. Bell, M.J., Robertson, C.S., Kochanek, P.M., Goodman, J.C., Gopinath, S.P., Carcillo, J.A., Clark, R.S., Marion, D.W., Mi, Z., Jackson, E.K. (2001) Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury. Crit. Care Med., 29, 399-404.
15. Benarroch, E.E. (2008) Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology, 70, 231-236.
16. Beraudi, A., Traversa, U., Villani, L., Sekino, Y., Nagy, J.I., Poli, A. (2003) Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain. Neurochem. Int., 42, 455-464.
17. Bjorklund, O., Shang, M., Tonazzini, I., Dare, E., Fredholm, B.B. (2008) Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage. Eur. J. Pharmacol., 596, 6-13.
18. Boison, D. (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist, 11, 25-36.
19. Boison, D. (2006) Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol. Sci., 27, 652-658.
20. Boison, D. (2008) Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol., 8, 2-7.
21. Boison, D. (2008) The adenosine kinase hypothesis of epileptogenesis. Prog. Neurobiol., 84, 249-262.
22. Borowiec, A., Lechward, K., Tkacz-Stachowska, K., Skladanowski, A.C. (2006) Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5′-nucleotidases. Acta Biochim. Pol., 53, 269-278.
23. Bruns, J., Jr., Hauser, W.A. (2003) The epidemiology of traumatic brain injury: a review. Epilepsia, 44 (Suppl 10), 2-10.
24. Buttner, T., Hornig, C.R., Busse, O., Dorndorf, W. (1986) CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction. J. Neurol., 233, 297-303.
25. Buytaert-Hoefen, K.A., Kreber, L.A., Millar, C.J., Walsh, U.T., Brannigan, C., Hernandez, T.D. (2002) Propentofylline after focal cortical lesion in the rat: impact on functional recovery and basic fibroblast growth factor expression. Neurosci. Lett., 331, 188-192.
26. Chen, J.F., Pedata, F. (2008) Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors. Curr. Pharm. Des., 14, 1490-1499.
27. Chen, J.F., Sonsalla, P.K., Pedata, F., Melani, A., Domenici, M.R., Popoli, P., Geiger, J., Lopes, L.V., de Mendonca, A. (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. Prog. Neurobiol., 83, 310-331.
28. Chesnut, R.M. (2004) Management of brain and spine injuries. Crit. Care Clin., 20, 25-55.
29. Chesnut, R.M., Marshall, L.F., Klauber, M.R., Blunt, B.A., Baldwin, N., Eisenberg, H.M., Jane, J.A., Marmarou, A., Foulkes, M.A. (1993) The role of secondary brain injury in determining outcome from severe head injury. J. Trauma, 34, 216-222.
30. Ciccarelli, R., Ballerini, P., Sabatino, G., Rathbone, M.P., D'Onofrio, M., Caciagli, F., Di Iorio, P. (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci., 19, 395-414.
31. Ciruela, F., Casado, V., Rodrigues, R.J., Lujan, R., Burgueno, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S.R., Mallol, J., Cortes, A., Canela, E.I., Lopez-Gimenez, J.F., Milligan, G., Lluis, C., Cunha, R.A., Ferre, S., Franco, R. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci., 26, 2080-2087.
32. Clark, R.S., Carcillo, J.A., Kochanek, P.M., Obrist, W.D., Jackson, E.K., Mi, Z., Wisneiwski, S.R., Bell, M.J., Marion, D.W. (1997) Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery, 41, 1284-1292; discussion 1292-1283.
33. Cruz, J., Jaggi, J.L., Hoffstad, O.J. (1995) Cerebral blood flow, vascular resistance, and oxygen metabolism in acute brain trauma: redefining the role of cerebral perfusion pressure? Crit. Care Med., 23, 1412-1417.
34. Cunha, R.A. (2008) Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochem. Int., 52, 65-72.
35. Cunha, R.A., Ferre, S., Vaugeois, J.M., Chen, J.F. (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr. Pharmaceut. Des., 14, 1512-1524.
36. D'Ambrosio, R., Fairbanks, J.P., Fender, J.S., Born, D.E., Doyle, D.L., Miller, J.W. (2004) Post-traumatic epilepsy following fluid percussion injury in the rat. Brain, 127, 304-314.
37. Dixon, A.K., Gubitz, A.K., Sirinathsinghji, D.J., Richardson, P.J., Freeman, T.C. (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol., 118, 1461-1468.
38. Dunwiddie, T.V., Masino, S.A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31-55.
39. Eckel-Mahan, K.L., Storm, D.R. (2008) Second Messengers: Calcium and cAMP Signaling. In: Byrne, J.H. Ed, Learning and Memory: A Comprehensive Reference. Academic Press: Oxford, pp. 427-448.
40. Elzein, E., Zablocki, J. (2008) A1 adenosine receptor agonists and their potential therapeutic applications. Exp. Opin. Investig. Drugs, 17, 1901-1910.
41. Fabian, M.J., Proctor, K.G. (2002) Hemodynamic actions of acute ethanol after resuscitation from traumatic brain injury. J. Trauma, 53, 864-875.
42. Fedele, D.E., Gouder, N., Guttinger, M., Gabernet, L., Scheurer, L., Rulicke, T., Crestani, F., Boison, D. (2005) Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain, 128, 2383-2395.
43. Ferre, S., Borycz, J., Goldberg, S.R., Hope, B.T., Morales, M., Lluis, C., Franco, R., Ciruela, F., Cunha, R. (2005) Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses. J. Integr. Neurosci., 4, 445-464.
44. Ferre, S., Quiroz, C., Woods, A.S., Cunha, R., Popoli, P., Ciruela, F., Lluis, C., Franco, R., Azdad, K., Schiffmann, S.N. (2008) An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr. Pharm. Des., 14, 1468-1474.
45. Fleischer, A.S., Rudman, D.R., Fresh, C.B., Tindall, G.T. (1977) Concentration of 3′,5′ cyclic adenosine monophosphate in ventricular CSF of patients following severe head trauma. J. Neurosurg., 47, 517-524.
46. Franco, R., Casado, V., Ciruela, F., Saura, C., Mallol, J., Canela, E.I., Lluis, C. (1997) Cell surface adenosine deaminase: much more than an ectoenzyme. Prog. Neurobiol., 52, 283-294.
47. Frassetto, S.S., Schetinger, M.R., Schierholt, R., Webber, A., Bonan, C.D., Wyse, A.T., Dias, R.D., Netto, C.A., Sarkis, J.J. (2000) Brain ischemia alters platelet ATP diphosphohydrolase and 5′-nucleotidase activities in naive and preconditioned rats. Braz. J. Med. Biol. Res., 33, 1369-1377.
48. Fredholm, B.B., Chen, J.F., Cunha, R.A., Svenningsson, P., Vaugeois, J.M. (2005) Adenosine and brain function. Int. Rev. Neurobiol., 63, 191-270.
49. Fredholm, B.B., Chen, J.F., Masino, S.A., Vaugeois, J.M. (2005) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol., 45, 385-412.
50. Frey, L.C. (2003) Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia, 44 (Suppl 10), 11-17.
51. Gaetz, M. (2004) The neurophysiology of brain injury. Clin. Neurophysiol., 115, 4-18.
52. Gao, Z.G., Jacobson, K.A. (2007) Emerging adenosine receptor agonists. Exp. Opin. Emerg. Drugs, 12, 479-492.
53. Gessi, S., Merighi, S., Varani, K., Leung, E., Mac Lennan, S., Borea, P.A. (2008) The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol. Ther., 117, 123-140.
54. Gimenez-Llort, L., Fernandez-Teruel, A., Escorihuela, R.M., Fredholm, B.B., Tobena, A., Pekny, M., Johansson, B. (2002) Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur. J. Neurosci., 16, 547-550.
55. Graham, D.I., Adams, J.H., Doyle, D. (1978) Ischaemic brain damage in fatal non-missile head injuries. J. Neurol. Sci., 39, 213-234.
56. Graham, D.I., Lawrence, A.E., Adams, J.H., Doyle, D., McLellan, D.R. (1987) Brain damage in non-missile head injury secondary to high intracranial pressure. Neuropathol. Appl. Neurobiol., 13, 209-217.
57. Gunduz-Bruce, H. (2009) The acute effects of NMDA antagonism: From the rodent to the human brain. Brain Res. Rev., 60, 279-286.
58. Halassa, M.M., Fellin, T., Haydon, P.G. (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med., 13, 54-63.
59. Harmar, A.J., Hills, R.A., Rosser, E.M., Jones, M., Buneman, O.P., Dunbar, D.R., Greenhill, S.D., Hale, V.A., Sharman, J.L., Bonner, T.I., Catterall, W.A., Davenport, A.P., Delagrange, P., Dollery, C.T., Foord, S.M., Gutman, G.A., Laudet, V., Neubig, R.R., Ohlstein, E.H., Olsen, R.W., Peters, J., Pin, J.P., Ruffolo, R.R., Searls, D.B., Wright, M.W., Spedding, M. (2009) IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res., 37, D680-685.
60. Hasko, G., Pacher, P. (2008) A2A receptors in inflammation and injury: lessons learned from transgenic animals. J. Leukoc. Biol., 83, 447-455.
61. Haydon, P.G., Carmignoto, G. (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev., 86, 1009-1031.
62. Headrick, J.P., Bendall, M.R., Faden, A.I., Vink, R. (1994) Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: potential role in secondary injury. J. Cereb. Blood Flow Metab., 14, 853-861.
63. Heath, D.L., Vink, R. (1999) Secondary mechanisms in traumatic brain injury: a nurse's perspective. J. Neurosci. Nurs., 31, 97-105.
64. Hilton, G. (2000) Cerebral oxygenation in the traumatically brain-injured patient: are ICP and CPP enough? J. Neurosci. Nurs., 32, 278-282.
65. Hoge, C.W., McGurk, D., Thomas, J.L., Cox, A.L., Engel, C.C., Castro, C.A. (2008) Mild traumatic brain injury in U.S. Soldiers returning from Iraq. New Engl. J. Med., 358, 453-463.
66. Jacobsson, L.J., Westerberg, M., Lexell, J. (2007) Demographics, injury characteristics and outcome of traumatic brain injuries in northern Sweden. Acta Neurol. Scand., 116, 300-306.
67. Jeremitsky, E., Omert, L., Dunham, C.M., Protetch, J., Rodriguez, A. (2003) Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J. Trauma, 54, 312-319.
68. Johansson, B., Halldner, L., Dunwiddie, T.V., Masino, S.A., Poelchen, W., Gimenez-Llort, L., Escorihuela, R.M., Fernandez-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.J., Hardemark, A., Betsholtz, C., Herlenius, E., Fredholm, B.B. (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA, 98, 9407-9412.
69. Kalda, A., Yu, L., Oztas, E., Chen, J.F. (2006) Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J. Neurol. Sci., 248, 9-15.
70. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S.F., Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science, 261, 466-469.
71. Kharatishvili, I., Nissinen, J.P., McIntosh, T.K., Pitkanen, A. (2006) A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience, 140, 685-697.
72. King, A.E., Ackley, M.A., Cass, C.E., Young, J.D., Baldwin, S.A. (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol. Sci., 27, 416-425.
73. Kochanek, P.M., Clark, R.S., Obrist, W.D., Carcillo, J.A., Jackson, E.K., Mi, Z., Wisniewski, S.R., Bell, M.J., Marion, D.W. (1997) The role of adenosine during the period of delayed cerebral swelling after severe traumatic brain injury in humans. Acta Neurochir. Suppl., 70, 109-111.
74. Kochanek, P.M., Hendrich, K.S., Jackson, E.K., Wisniewski, S.R., Melick, J.A., Shore, P.M., Janesko, K.L., Zacharia, L., Ho, C. (2005) Characterization of the effects of adenosine receptor agonists on cerebral blood flow in uninjured and traumatically injured rat brain using continuous arterial spin-labeled magnetic resonance imaging. J. Cereb. Blood Flow Metab., 25, 1596-1612.
75. Kochanek, P.M., Hendrich, K.S., Robertson, C.L., Williams, D.S., Melick, J.A., Ho, C., Marion, D.W., Jackson, E.K. (2001) Assessment of the effect of 2-chloroadenosine in normal rat brain using spin-labeled MRI measurement of perfusion. Magn. Reson. Med., 45, 924-929.
76. Kochanek, P.M., Vagni, V.A., Janesko, K.L., Washington, C.B., Crumrine, P.K., Garman, R.H., Jenkins, L.W., Clark, R.S., Homanics, G.E., Dixon, C.E., Schnermann, J., Jackson, E.K. (2006) Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J. Cereb. Blood Flow Metab., 26, 565-575.
77. Kuno, M., Seki, N., Tsujimoto, S., Nakanishi, I., Kinoshita, T., Nakamura, K., Terasaka, T., Nishio, N., Sato, A., Fujii, T. (2006) Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. Eur. J. Pharmacol., 534, 241-249.
78. Kwok, F.Y., Lee, T.M., Leung, C.H., Poon, W.S. (2008) Changes of cognitive functioning following mild traumatic brain injury over a 3-month period. Brain Inj., 22, 740-751.
79. Lambeir, A.M., Durinx, C., Scharpe, S., De Meester, I. (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci., 40, 209-294.
80. Landolt, H.P. (2008) Sleep homeostasis: a role for adenosine in humans? Biochem. Pharmacol., 75, 2070-2079.
81. Langlois, J.A., Rutland-Brown, W., Thomas, K.E. (2006) Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
82. LaPlaca, M.C., Lee, V.M., Thibault, L.E. (1997) An in vitro model of traumatic neuronal injury: loading rate-dependent changes in acute cytosolic calcium and lactate dehydrogenase release. J. Neurotrauma, 14, 355-368.
83. Latini, S., Pedata, F. (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem., 79, 463-484.
84. Li, T., Ren, G., Lusardi, T., Wilz, A., Lan, J.Q., Iwasato, T., Itohara, S., Simon, R.P., Boison, D. (2008) Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J. Clin. Invest., 118, 571-582.
85. Li, T., Steinbeck, J.A., Lusardi, T., Koch, P., Lan, J.Q., Wilz, A., Segschneider, M., Simon, R.P., Brustle, O., Boison, D. (2007) Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain, 130, 1276-1288.
86. Li, W., Dai, S., An, J., Li, P., Chen, X., Xiong, R., Liu, P., Wang, H., Zhao, Y., Zhu, M., Liu, X., Zhu, P., Chen, J.F., Zhou, Y. (2008) Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model. Neuroscience, 151, 1198-1207.
87. Li, W., Dai, S., An, J., Xiong, R., Li, P., Chen, X., Zhao, Y., Liu, P., Wang, H., Zhu, P., Chen, J., Zhou, Y. (2009) Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model. Exp. Neurol., 215, 69-76.
88. Li, X., Zhou, T., Zhi, X., Zhao, F., Yin, L., Zhou, P. (2006) Effect of hypoxia/reoxygenation on CD73 (ecto-5′-nucleotidase) in mouse microvessel endothelial cell lines. Microvasc. Res., 72, 48-53.
89. Lin, Y., Phillis, J.W. (1992) Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the rat. Brain Res., 571, 272-280.
90. Linden, J. (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol., 41, 775-787.
91. Lusardi, T.A., Wolf, J.A., Putt, M.E., Smith, D.H., Meaney, D.F. (2004) Effect of acute calcium influx after mechanical stretch injury in vitro on the viability of hippocampal neurons. J. Neurotrauma, 21, 61-72.
92. Mackiewicz, M., Nikonova, E.V., Zimmerman, J.E., Galante, R.J., Zhang, L., Cater, J.R., Geiger, J.D., Pack, A.I. (2003) Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation. J. Neurochem., 85, 348-357.
93. Mackiewicz, M., Nikonova, E.V., Zimmermann, J.E., Romer, M.A., Cater, J., Galante, R.J., Pack, A.I. (2006) Age-related changes in adenosine metabolic enzymes in sleep/wake regulatory areas of the brain. Neurobiol. Aging, 27, 351-360.
94. Maida, E., Kristoferitsch, W. (1981) Cyclic adenosine 3′,5′ monophosphate in cerebrospinal fluid of multiple sclerosis patients. J. Neurol., 225, 145-151.
95. Marik, P.E., Varon, J., Trask, T. (2002) Management of head trauma. Chest, 122, 699-711.
96. McCarley, R.W. (2007) Neurobiology of REM and NREM sleep. Sleep Med., 8, 302-330.
97. Miller, J.D., Adams, J.H. (1992) The pathophysiology of raised intracranial pressure. In: Adams, J.H., Duchen, L.W. Eds, Greenfield's Neuropathology. Oxford University Press: New York, pp. 69-105.
98. Moore, E.L., Terryberry-Spohr, L., Hope, D.A. (2006) Mild traumatic brain injury and anxiety sequelae: a review of the literature. Brain Inj., 20, 117-132.
99. Moriwaki, Y., Yamamoto, T., Higashino, K. (1999) Enzymes involved in purine metabolism - a review of histochemical localization and functional implications. Histol. Histopathol., 14, 1321-1340.
100. Myllyla, V.V., Heikkinen, E.R., Vapaatalo, H., Hokkanen, E. (1975) Cyclic amp concentration and enzyme activities of cerebrospinal fluid in patients with epilepsy or central nervous system damage. Eur. Neurol., 13, 123-130.
101. Najm, I., Ying, Z., Janigro, D. (2001) Mechanisms of epileptogenesis. Neurol. Clin., 19, 237-250.
102. Nampiaparampil, D.E. (2008) Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA, 300, 711-719.
103. Nedeljkovic, N., Bjelobaba, I., Lavrnja, I., Stojkov, D., Pekovic, S., Rakic, L., Stojiljkovic, M. (2008) Early temporal changes in ectonucleotidase activity after cortical stab injury in rat. Neurochem. Res., 33, 873-879.
104. Nedeljkovic, N., Bjelobaba, I., Subasic, S., Lavrnja, I., Pekovic, S., Stojkov, D., Vjestica, A., Rakic, L., Stojiljkovic, M. (2006) Up-regulation of ectonucleotidase activity after cortical stab injury in rats. Cell. Biol. Int., 30, 541-546.
105. Nestvold, K., Stavem, K. (2009) Determinants of health-related quality of life 22 years after hospitalization for traumatic brain injury. Brain Inj., 23, 15-21.
106. Noji, T., Karasawa, A., Kusaka, H. (2004) Adenosine uptake inhibitors. Eur. J. Pharmacol., 495, 1-16.
107. Novack, T.A., Alderson, A.L., Bush, B.A., Meythaler, J.M., Canupp, K. (2000) Cognitive and functional recovery at 6 and 12 months post-TBI. Brain Inj., 14, 987-996.
108. Obrist, W.D., Langfitt, T.W., Jaggi, J.L., Cruz, J., Gennarelli, T.A. (1984) Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension. J. Neurosurg., 61, 241-253.
109. Parkinson, F.E., Xiong, W. (2004) Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J. Neurochem., 88, 1305-1312.
110. Parkinson, F.E., Xiong, W., Zamzow, C.R. (2005) Astrocytes and neurons: different roles in regulating adenosine levels. Neurol. Res., 27, 153-160.
111. Peart, J.N., Headrick, J.P. (2007) Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol. Ther., 114, 208-221.
112. Phillips, E., Newsholme, E.A. (1979) Maximum activities, properties and distribution of 5′ nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J. Neurochem., 33, 553-558.
113. Phillis, J.W., Goshgarian, H.G. (2001) Adenosine and neurotrauma: therapeutic perspectives. Neurol. Res., 23, 183-189.
114. Pignataro, G., Maysami, S., Studer, F.E., Wilz, A., Simon, R.P., Boison, D. (2008) Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J. Cereb. Blood Flow Metab., 28, 17-23.
115. Pignataro, G., Simon, R.P., Boison, D. (2006) Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J. Cereb. Blood Flow Metab. 27, 1-5.
116. Pugliese, A.M., Coppi, E., Volpini, R., Cristalli, G., Corradetti, R., Jeong, L.S., Jacobson, K.A., Pedata, F. (2007) Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration. Biochem. Pharmacol., 74, 768-779.
117. Rathbone, M.P., Middlemiss, P.J., Gysbers, J.W., Andrew, C., Herman, M.A., Reed, J.K., Ciccarelli, R., Di Iorio, P., Caciagli, F. (1999) Trophic effects of purines in neurons and glial cells. Prog. Neurobiol., 59, 663-690.
118. Rebola, N., Canas, P.M., Oliveira, C.R., Cunha, R.A. (2005) Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. Neuroscience, 132, 893-903.
119. Ribeiro, J.A. (2005) What can adenosine neuromodulation do for neuroprotection? Curr. Drug Targets CNS Neurol. Disord., 4, 325-329.
120. Robertson, C.L., Bell, M.J., Kochanek, P.M., Adelson, P.D., Ruppel, R.A., Carcillo, J.A., Wisniewski, S.R., Mi, Z., Janesko, K.L., Clark, R.S., Marion, D.W., Graham, S.H., Jackson, E.K. (2001) Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit. Care Med., 29, 2287-2293.
121. Rodrigues, R.J., Alfaro, T.M., Rebola, N., Oliveira, C.R., Cunha, R.A. (2005) Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem., 92, 433-441.
122. Ronne-Engstrom, E., Winkler, T. (2006) Continuous EEG monitoring in patients with traumatic brain injury reveals a high incidence of epileptiform activity. Acta Neurol. Scand., 114, 47-53.
123. Rossi, D.J., Brady, J.D., Mohr, C. (2007) Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci., 10, 1377-1386.
124. Rudman, D., Fleischer, A., Kutner, M.H. (1976) Concentration of 3′, 5′ cyclic adenosine monophosphate in ventricular cerebrospinal fluid of patients with prolonged coma after head trauma or intracranial hemorrhage. N. Engl. J. Med., 295, 635-638.
125. Rzigalinski, B.A., Weber, J.T., Willoughby, K.A., Ellis, E.F. (1998) Intracellular free calcium dynamics in stretch-injured astrocytes. J. Neurochem., 70, 2377-2385.
126. Sachse, K.T., Jackson, E.K., Wisniewski, S.R., Gillespie, D.G., Puccio, A.M., Clark, R.S., Dixon, C.E., Kochanek, P.M. (2008) Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans. J. Cereb. Blood Flow Metab., 28, 395-401.
127. Sawynok, J., Liu, X.J. (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol., 69, 313-340.
128. Sciotti, V.M., Van Wylen, D.G. (1993) Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J. Cereb. Blood Flow Metab., 13, 201-207.
129. Shore, P.M., Jackson, E.K., Wisniewski, S.R., Clark, R.S., Adelson, P.D., Kochanek, P.M. (2004) Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. Neurosurgery, 54, 605-611; discussion 611-602.
130. Simola, N., Morelli, M., Pinna, A. (2008) Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions. Curr. Pharm. Des., 14, 1475-1489.
131. Statler, K.D. (2006) Pediatric posttraumatic seizures: epidemiology, putative mechanisms of epileptogenesis and promising investigational progress. Dev. Neurosci., 28, 354-363.
132. Stenberg, D. (2007) Neuroanatomy and neurochemistry of sleep. Cell Mol. Life Sci., 64, 1187-1204.
133. Stone, T.W. (2002) Purines and neuroprotection. Adv. Exp. Med. Biol., 513, 249-280.
134. Studer, F.E., Fedele, D.E., Marowsky, A., Schwerdel, C., Wernli, K., Vogt, K., Fritschy, J.M., Boison, D. (2006) Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience, 142, 125-137.
135. Tebano, M.T., Martire, A., Rebola, N., Pepponi, R., Domenici, M.R., Gro, M.C., Schwarzschild, M.A., Chen, J.F., Cunha, R.A., Popoli, P. (2005) Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. J. Neurochem., 95, 1188-1200.
136. Temkin, N.R., Machamer, J.E., Dikmen, S.S. (2003) Correlates of functional status 3-5 years after traumatic brain injury with CT abnormalities. J. Neurotrauma., 20, 229-241.
137. Trevethick, M.A., Mantell, S.J., Stuart, E.F., Barnard, A., Wright, K.N., Yeadon, M. (2008) Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions. Br. J. Pharmacol., 155, 463-474.
138. Varma, M.R., Dixon, C.E., Jackson, E.K., Peters, G.W., Melick, J.A., Griffith, R.P., Vagni, V.A., Clark, R.S., Jenkins, L.W., Kochanek, P.M. (2002) Administration of adenosine receptor agonists or antagonists after controlled cortical impact in mice: effects on function and histopathology. Brain Res., 951, 191-201.
139. Vass, G., Horvath, I. (2008) Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr. Med. Chem., 15, 917-922.
140. Vazquez, J.F., Clement, H.W., Sommer, O., Schulz, E., van Calker, D. (2008) Local stimulation of the adenosine A2B receptors induces an increased release of IL-6 in mouse striatum: an in vivo microdialysis study. J. Neurochem., 105, 904-909.
141. Verma, A., Anand, V., Verma, N.P. (2007) Sleep disorders in chronic traumatic brain injury. J. Clin. Sleep Med., 3, 357-362.
142. Verweij, B.H., Amelink, G.J., Muizelaar, J.P. (2007) Current concepts of cerebral oxygen transport and energy metabolism after severe traumatic brain injury. Prog. Brain Res., 161, 111-124.
143. Vespa, P., Bergsneider, M., Hattori, N., Wu, H.M., Huang, S.C., Martin, N.A., Glenn, T.C., McArthur, D.L., Hovda, D.A. (2005) Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J. Cereb. Blood Flow Metab., 25, 763-774.
144. Vianna, E.P., Ferreira, A.T., Dona, F., Cavalheiro, E.A., da Silva Fernandes, M.J. (2005) Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia, 46 (Suppl 5), 166-173.
145. Wartenberg, K.E., Schmidt, J.M., Mayer, S.A. (2007) Multimodality monitoring in neurocritical care. Crit. Care Clin., 23, 507-538.
146. Weber, J.T. (2004) Calcium homeostasis following traumatic neuronal injury. Curr. Neurovasc. Res., 1, 151-171.
147. Wilson, C.N. (2008) Adenosine receptors and asthma in humans. Br. J. Pharmacol., 155, 475-486.
148. Zaccolo, M., Magalhaes, P., Pozzan, T. (2002) Compartmentalisation of cAMP and Ca(2+) signals. Curr. Opin. Cell Biol., 14, 160-166.
149. Zhou, A.M., Li, W.B., Li, Q.J., Liu, H.Q., Feng, R.F., Zhao, H.G. (2004) A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci. Res., 48, 397-404.
150. Zink, B.J. (2001) Traumatic brain injury outcome: concepts for emergency care. Ann. Emerg. Med., 37, 318-332.